30 Oct
|
Telix Pharmaceuticals
|
Australia
30 Oct
Telix Pharmaceuticals
Australia
Telix Pharmaceuticals Limited is seeking a seasoned CMC Program Lead to oversee antibody-based radiopharmaceutical programs TLX597 & TLX66. You will drive CMC strategy across preclinical through phase 3, coordinating internal sites and external partners with a solid emphasis on QbD, risk management, and Stage-Gate readiness.
You will manage a cross-functional team, ensure timely deliverables, and communicate with senior management regarding timelines and resource needs.
#J-18808-Ljbffr
📌 CMC Program Lead, Radiopharmaceuticals (Australia)
🏢 Telix Pharmaceuticals
📍 Australia